drugset / Trial / NCT00651313

Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods)

NCT00651313

Phase 2 Completed 81 enrolled Juniper Pharmaceuticals, Inc.
RandomizedCrossoverQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether lidocaine vaginal gel is safe and effective for preventing or reducing the severity of dysmenorrhea (painful menstrual periods) compared to placebo (inactive gel).

Timeline

Start
2007-08
Primary completion
2008-06
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 150 mg Other

Indications